Nantahala Capital Management’s VIVEVE MED INC VIVE Stock Holding History

Nantahala Capital Management’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6,581	Closed	-$2.5M	–	99
2019 Q2	$2.5M	Hold	6,581	–	–	0.08%	86
2019 Q1	$6.18M	Hold	6,581	–	–	0.19%	70
2018 Q4	$6.91M	Buy	6,581 +2,633	+67%	+$6.32M	0.21%	67
2018 Q3	$10.6M	Hold	3,948	–	–	0.28%	51
2018 Q2	$10.7M	Buy	3,948 +1,101	+39%	+$3.17M	0.43%	50
2018 Q1	$10.4M	Buy	+2,847	New	+$12.4M	0.47%	44

Other funds holding VIVE

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Nantahala Capital Management's VIVE Position: Q3 2019 in Review

Nantahala Capital Management sold out of VIVEVE MED INC (VIVE) in Q3 2019, closing a stake of 6,581 shares — an estimated $2.5M sold.

Nantahala Capital Management first reported a position in VIVE in Q1 2018 and held it in 6 quarters. The position peaked at $10.7M in Q2 2018. 11 funds tracked by Wall St. Rank hold VIVE as of Q3 2019.

Nantahala Capital Management reported no remaining VIVEVE MED INC position as of Q3 2019 after selling out during the quarter.
Nantahala Capital Management sold 6,581 VIVEVE MED INC shares in Q3 2019, an estimated $2.5M.
Nantahala Capital Management first reported a position in VIVEVE MED INC in Q1 2018 and held it in 6 quarters.
Nantahala Capital Management's VIVEVE MED INC position peaked at $10.7M in Q2 2018.
11 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q3 2019.

Based on Nantahala Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.